CORRECTION article

Front. Genet., 04 December 2024

Sec. Cancer Genetics and Oncogenomics

Volume 15 - 2024 | https://doi.org/10.3389/fgene.2024.1531321

Corrigendum: Immune regulation and prognostic prediction model establishment and validation of PSMB6 in lung adenocarcinoma

  • 1. Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China

  • 2. North Sichuan Medical College, Nanchong, China

  • 3. Department of Thoracic Surgery, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China

  • 4. North Sichuan Medical College, Innovation Centre for Science and Technology, Nanchong, China

  • 5. Department of Oncology, Affiliated Hospital of North Sichuan Medical College, Nanchong, China

  • 6. Nanchong Central Hospital, Nanchong, Sichuan, China

  • 7. Therapeutic Proteins Key Laboratory of Sichuan Province, Nanchong, China

In the published article, there was an error regarding the Affiliations listed for Haiyang Zhao, Kexin Luo, Meihan Liu, Yongsheng Zhao and Hongpan Zhang. In addition to their existing Affiliations, they should also have Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China listed to their names.

The corrected Affiliations are listed below:

Haiyang Zhao1,2,3,4,†, Kexin Luo1,2,3,4,†, Meihan Liu1,2,4,5,†, Yuanze Cai2, Siman Liu2, Shijuan Li6, Yongsheng Zhao1,2,3,*, Hongpan Zhang1,2,5,7,*

1.Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China

2.North Sichuan Medical College, Nanchong, China

3.Department of Thoracic Surgery, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China

4.North Sichuan Medical College, Innovation Centre for Science and Technology, Nanchong, China

5.Department of Oncology, Affiliated Hospital of North Sichuan Medical College, Nanchong, China

6.Nanchong Central Hospital, Nanchong, Sichuan, China

7.Therapeutic Proteins Key Laboratory of Sichuan Province, Nanchong, China

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

lung adenocarcinoma, PSMB6, immunotherapy, immune infiltration, tumor immune microenvironment

Citation

Zhao H, Luo K, Liu M, Cai Y, Liu S, Li S, Zhao Y and Zhang H (2024) Corrigendum: Immune regulation and prognostic prediction model establishment and validation of PSMB6 in lung adenocarcinoma. Front. Genet. 15:1531321. doi: 10.3389/fgene.2024.1531321

Received

20 November 2024

Accepted

21 November 2024

Published

04 December 2024

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

15 - 2024

Updates

Copyright

*Correspondence: Yongsheng Zhao, ; Hongpan Zhang,

† These authors have contributed equally to this work

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics